Acquisition - HealthQuill

Cordis, a US-based medical device maker, has acquired Switzerland’s MedAlliance for up to $1.1 billion to expand its product portfolio.

Cordis acquires medical device maker MedAlliance for $1.1 billion

HQ Team October 2, 2023: Cordis, a US-based medical device maker, has acquired Switzerland’s MedAlliance for up to $1.1 billion to expand its.

by HealthQuill
October 2, 2023
0 Comments

Biocon Ltd., an Indian biopharmaceutical company, has acquired Eywa Pharma Inc., an oral solid dosage manufacturing facility in the US for $7.7 million.

Drugs Health Pharma

Biocon buys Eywa Pharma’s US facility for $7.7 million

HQ Team September 6, 2023: Biocon Ltd., an Indian biopharmaceutical company, has acquired Eywa Pharma Inc., an oral solid dosage manufacturing facility in.

by HealthQuill
September 6, 2023
0 Comments

Eli Lily sold its sugar-controlling drug to Amphastar Pharmaceuticals for $1.07 billion.

Drugs Health Pharma

Eli Lilly to sell diabetic nasal drug to Amphastar for $1.07 billion

Eli Lily sold its sugar-controlling drug to Amphastar Pharmaceuticals for $1.07 billion.

by HealthQuill
April 25, 2023
0 Comments

US-based Merck will buy Prometheus Biosciences for about 10.8 billion to shore up its immunology portfolio to shield itself from eventual revenue loss as patents on its cancer immunotherapy Keytruda expires by the end of the decade.

Drugs Pharma

Merck to acquire Prometheus for $10.8 billion to step up immunology presence

HQ Team April 17, 2023: US-based Merck will buy Prometheus Biosciences for about 10.8 billion to shore up its immunology portfolio to shield itself from.

by HealthQuill
April 17, 2023
0 Comments

Dr. Reddy’s Laboratories, an Indian maker of generics and active pharmaceutical ingredients, has completed the acquisition of Mayne Pharma’s U.S. generic prescription portfolio.

Drugs Health Medical Pharma

Dr. Reddy’s completes Mayne Pharma’s U.S. portfolio buyout

H.Q. Team April 7, 2023: Dr. Reddy’s Laboratories, an Indian maker of generics and active pharmaceutical ingredients, has completed the acquisition of Mayne.

by HealthQuill
April 7, 2023
0 Comments

Pfizer will acquire Seagen for $43 billion to beef up its cancer portfolio, with COVID-19 vaccine sales forecast to plummet.

Drugs Medical Pharma

Pfizer to buy Seagen for $43 billion to fortify cancer portfolio

Pfizer will acquire Seagen for $43 billion to beef up its cancer portfolio, with COVID-19 vaccine sales forecast to plummet.

by HealthQuill
March 13, 2023
0 Comments

Globus Medical, a US-based publicly traded medical device company making products to treat musculoskeletal disorders, acquired NuVasive in an all-stock deal worth $3.1 billion

Drugs Medical Pharma

Globus Medical buys NuVasive in all-stock for $3.1 billion

Globus Medical, a US-based publicly traded medical device company making products to treat musculoskeletal disorders, acquired NuVasive in an all-stock deal worth $3.1.